The global directconsumer genetic testing market is expected to grow at a CAGR of 12.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing awareness about genetic disorders and diseases among people, which in turn leads to an increase in demand for directconsumer genetic tests. Moreover, the increasing number of research and development activities in this field are also driving the growth of this market. The global directconsumer genetic testing market can be segmented on the basis of type into diagnostic screening, prenatal, newborn screening, and preimplantation diagnosis; on the basis of application into online and offline; and on the basis of region into North America, Latin America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA). The diagnostic screening segment accounted for a major share in 2018 owing to its wide range applications such as cancer detection or diagnosis for hereditary diseases such as cystic fibrosis or Huntington’s disease. The prenatal segment is expected to grow at a higher CAGR during 2020-2030 owing to its wide range applications such as detecting Down syndrome or other chromosomal abnormalities before birth.
Some Of The Growth Factors Of This Market:
- The market for direct-to-consumer genetic testing is growing due to the increased availability of affordable genetic testing kits and the increased awareness of the benefits of genetic testing.
- The market for direct-to-consumer genetic testing is expected to grow as more people are becoming aware of their risk factors and want to take control over their health by knowing what they are at risk for.
- Direct-to-consumer genetic tests can be used in a variety of ways, such as determining if someone has a gene that makes them more susceptible to certain diseases or conditions, determining if someone is at risk for passing on a hereditary disease or condition, and determining if someone has an increased chance of developing certain diseases or conditions in the future.
- Direct-to-consumer genetics tests can be used by doctors to help diagnose patients with rare disorders that may not have been previously diagnosed because they were not looking for it specifically, but rather just looking at all possible causes based on symptoms presented by the patient.
- Genetic information can also be used by doctors when deciding which treatments would work best with each individual's DNA.
Industry Growth Insights published a new data on “Direct-to-consumer Genetic Testing Market”. The research report is titled “Direct-to-consumer Genetic Testing Market research by Types (Diagnostic Screening, Prenatal, Newborn Screening, and Pre-Implantation Diagnosis, Relationship Testing, Direct-to-consumer Genetic Testin), By Applications (Online, Offline), By Players/Companies 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes, Direct-to-consumer Genetic Testin”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Direct-to-consumer Genetic Testing Market Research Report
By Type
Diagnostic Screening, Prenatal, Newborn Screening, and Pre-Implantation Diagnosis, Relationship Testing, Direct-to-consumer Genetic Testin
By Application
Online, Offline
By Companies
23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes, Direct-to-consumer Genetic Testin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Direct-to-consumer Genetic Testing Market Report Segments:
The global Direct-to-consumer Genetic Testing market is segmented on the basis of:
Types
Diagnostic Screening, Prenatal, Newborn Screening, and Pre-Implantation Diagnosis, Relationship Testing, Direct-to-consumer Genetic Testin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Online, Offline
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 23andMe
- MyHeritage
- LabCorp
- Myriad Genetics
- Ancestry.com
- Quest Diagnostics
- Gene By Gene
- DNA Diagnostics Center
- Invitae
- IntelliGenetics
- Ambry Genetics
- Living DNA
- EasyDNA
- Pathway Genomics
- Centrillion Technology
- Xcode
- Color Genomics
- Anglia DNA Services
- African Ancestry
- Canadian DNA Services
- DNA Family Check
- Alpha Biolaboratories
- Test Me DNA
- 23 Mofang
- Genetic Health
- DNA Services of America
- Shuwen Health Sciences
- Mapmygenome
- Full Genomes
- Direct-to-consumer Genetic Testin
Highlights of The Direct-to-consumer Genetic Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnostic Screening
- Prenatal, Newborn Screening, and Pre-Implantation Diagnosis
- Relationship Testing
- Direct-to-consumer Genetic Testin
- By Application:
- Online
- Offline
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Direct-to-consumer Genetic Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Direct-to-consumer genetic testing is a process by which individuals can order tests that assess their personal risk for certain diseases or conditions. These tests are typically offered through online platforms and may be marketed to consumers as a way to better understand their health and potential risks. While direct-to-consumer genetic testing has the potential to provide valuable information about an individual's health, it is also possible for these tests to be inaccurate or misleading.
Some of the key players operating in the direct-to-consumer genetic testing market are 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes, Direct-to-consumer Genetic Testin.
The direct-to-consumer genetic testing market is expected to register a CAGR of 12.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Direct-to-consumer Genetic Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Direct-to-consumer Genetic Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Direct-to-consumer Genetic Testing Market - Supply Chain
4.5. Global Direct-to-consumer Genetic Testing Market Forecast
4.5.1. Direct-to-consumer Genetic Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Direct-to-consumer Genetic Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Direct-to-consumer Genetic Testing Market Absolute $ Opportunity
5. Global Direct-to-consumer Genetic Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Type
5.3.1. Diagnostic Screening
5.3.2. Prenatal, Newborn Screening, and Pre-Implantation Diagnosis
5.3.3. Relationship Testing
5.3.4. Direct-to-consumer Genetic Testin
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Direct-to-consumer Genetic Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Application
6.3.1. Online
6.3.2. Offline
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Direct-to-consumer Genetic Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Direct-to-consumer Genetic Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Direct-to-consumer Genetic Testing Demand Share Forecast, 2019-2026
9. North America Direct-to-consumer Genetic Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Application
9.4.1. Online
9.4.2. Offline
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Type
9.7.1. Diagnostic Screening
9.7.2. Prenatal, Newborn Screening, and Pre-Implantation Diagnosis
9.7.3. Relationship Testing
9.7.4. Direct-to-consumer Genetic Testin
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Direct-to-consumer Genetic Testing Demand Share Forecast, 2019-2026
10. Latin America Direct-to-consumer Genetic Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Application
10.4.1. Online
10.4.2. Offline
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Type
10.7.1. Diagnostic Screening
10.7.2. Prenatal, Newborn Screening, and Pre-Implantation Diagnosis
10.7.3. Relationship Testing
10.7.4. Direct-to-consumer Genetic Testin
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Direct-to-consumer Genetic Testing Demand Share Forecast, 2019-2026
11. Europe Direct-to-consumer Genetic Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Application
11.4.1. Online
11.4.2. Offline
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Type
11.7.1. Diagnostic Screening
11.7.2. Prenatal, Newborn Screening, and Pre-Implantation Diagnosis
11.7.3. Relationship Testing
11.7.4. Direct-to-consumer Genetic Testin
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Direct-to-consumer Genetic Testing Demand Share, 2019-2026
12. Asia Pacific Direct-to-consumer Genetic Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Application
12.4.1. Online
12.4.2. Offline
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Type
12.7.1. Diagnostic Screening
12.7.2. Prenatal, Newborn Screening, and Pre-Implantation Diagnosis
12.7.3. Relationship Testing
12.7.4. Direct-to-consumer Genetic Testin
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Direct-to-consumer Genetic Testing Demand Share, 2019-2026
13. Middle East & Africa Direct-to-consumer Genetic Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Application
13.4.1. Online
13.4.2. Offline
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Direct-to-consumer Genetic Testing Market Size and Volume Forecast by Type
13.7.1. Diagnostic Screening
13.7.2. Prenatal, Newborn Screening, and Pre-Implantation Diagnosis
13.7.3. Relationship Testing
13.7.4. Direct-to-consumer Genetic Testin
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Direct-to-consumer Genetic Testing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Direct-to-consumer Genetic Testing Market: Market Share Analysis
14.2. Direct-to-consumer Genetic Testing Distributors and Customers
14.3. Direct-to-consumer Genetic Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. 23andMe
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. MyHeritage
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. LabCorp
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Myriad Genetics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Ancestry.com
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Quest Diagnostics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Gene By Gene
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. DNA Diagnostics Center
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Invitae
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. IntelliGenetics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Ambry Genetics
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Living DNA
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. EasyDNA
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Pathway Genomics
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Centrillion Technology
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Xcode
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Color Genomics
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Anglia DNA Services
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. African Ancestry
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Canadian DNA Services
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook